extended half-life factor VIII concentrate, for use in pediatric patients 7 years of age and older with hemophilia A (congenital Factor VIII deficiency). The approval is based on data from the ...

Factor VII deficiency is a rare genetic disorder. It occurs when your body can’t produce enough clotting factor VII, which helps in healing wounds. It can be hereditary or be caused by an ...

A new X Factor starts tonight with judges Guy Sebastian, James Blunt and Chris Isaak joining Dannii Minogue. The search for the new sound in Australian music returns, with the first round of ...

INDIANAPOLIS--(BUSINESS WIRE)--Factor 7 Medical (F7M), a leading advisory group for medical technology companies, is launching an aggressive growth strategy through a mutual acquisition agreement with ...

The bleeding profile, unfavourable pharmacokinetics (PKs), low adherence and high daily activity were patient profiles that would benefit from using the extended half-life (EHL) recombinant factor ...

The use of a natural complement regulator such as factor H (FH) could provide a superior treatment ... As expected, CPV-104 showed a significantly longer serum half-life (~2.7 h) than CPV-101. The ...

Blood coagulation factor VIII deficiency is classified as hemophilia type ... TU7710 is a long-acting rFVIIa with a half-life 6-7 times longer than NovoSeven, a rFVIIa widely accepted as a standard ...

The insulin-like growth factor (IGF)-insulin-like growth factor binding protein (IGFBP) system is closely associated with the maintenance and differentiation of MSCs. It is involved in age-related ...

Introduction: Factor VII deficiency is a rare inherited autosomal recessive bleeding disorder with a global prevalence of 1/500,000. Most cases remain asymptomatic, and cases with severe clinical ...